Isolation and characterization of two sub-species of Lp(a), one containing apo E and one free of apo E. 1992

J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
SERLIA, Institut Pasteur, Lille, France.

Lipoprotein Lp(a) was isolated by immunoaffinity chromatography using anti apolipoprotein B and anti apolipoprotein (a) immunosorbents. Besides apolipoproteins (a) and B, this fraction was shown to contain apolipoproteins C and E. Therefore, it was decided to further purify this crude Lp(a) into particles containing apolipoprotein E and particles free of apo E, using chromatography with an anti apolipoprotein E immunosorbent. Lp(a), free of apolipoprotein E was cholesterol ester rich and triacylglycerol poor and was found mainly in the LDL size range. In contrast, Lp(a) containing apolipoprotein E was triacylglycerol rich and was distributed mainly in the VLDL and IDL size range. Binding of these two fractions, one containing apo E and one free of it, to the apo B/E receptor of HeLa cells was studied. Both fractions bound to the receptor but the one containing apo E had a better affinity than the one free of apo E. Further studies are needed to identify the clinical importance of these two different entities.

UI MeSH Term Description Entries
D008055 Lipids A generic term for fats and lipoids, the alcohol-ether-soluble constituents of protoplasm, which are insoluble in water. They comprise the fats, fatty oils, essential oils, waxes, phospholipids, glycolipids, sulfolipids, aminolipids, chromolipids (lipochromes), and fatty acids. (Grant & Hackh's Chemical Dictionary, 5th ed) Lipid
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D010316 Particle Size Relating to the size of solids. Particle Sizes,Size, Particle,Sizes, Particle
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D002846 Chromatography, Affinity A chromatographic technique that utilizes the ability of biological molecules, often ANTIBODIES, to bind to certain ligands specifically and reversibly. It is used in protein biochemistry. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Chromatography, Bioaffinity,Immunochromatography,Affinity Chromatography,Bioaffinity Chromatography
D006367 HeLa Cells The first continuously cultured human malignant CELL LINE, derived from the cervical carcinoma of Henrietta Lacks. These cells are used for, among other things, VIRUS CULTIVATION and PRECLINICAL DRUG EVALUATION assays. Cell, HeLa,Cells, HeLa,HeLa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001053 Apolipoproteins Protein components on the surface of LIPOPROTEINS. They form a layer surrounding the hydrophobic lipid core. There are several classes of apolipoproteins with each playing a different role in lipid transport and LIPID METABOLISM. These proteins are synthesized mainly in the LIVER and the INTESTINES. Apolipoprotein
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E
D017270 Lipoprotein(a) A lipoprotein that resembles the LOW-DENSITY LIPOPROTEINS but with an extra protein moiety, APOPROTEIN (A) also known as APOLIPOPROTEIN (A), linked to APOLIPOPROTEIN B-100 on the LDL by one or two disulfide bonds. High plasma level of lipoprotein (a) is associated with increased risk of atherosclerotic cardiovascular disease. Lipoprotein (a),Lipoprotein (a-),Lipoprotein Lp(a),Lipoprotein a

Related Publications

J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
January 1994, Chemistry and physics of lipids,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
June 1976, Biochimica et biophysica acta,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
April 1982, Atherosclerosis,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
June 1997, Atherosclerosis,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
January 1988, Journal of immunoassay,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
March 1991, Biochimica et biophysica acta,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
May 1988, Journal of lipid research,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
March 2020, Arteriosclerosis, thrombosis, and vascular biology,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
September 1996, Journal of lipid research,
J M Bard, and S Delattre-Lestavel, and V Clavey, and P Pont, and B Derudas, and H J Parra, and J C Fruchart
January 1990, Japanese journal of medicine,
Copied contents to your clipboard!